Division of Renal Diseases and Hypertension, Transplant Center, University of Colorado Denver, Aurora, Colorado, USA.
Curr Opin Nephrol Hypertens. 2013 Nov;22(6):698-703. doi: 10.1097/MNH.0b013e328365b388.
Acute kidney injury (AKI) in transplant recipients is a prevalent condition with a broad list of potential inciting causes. This review highlights recent data describing the epidemiology and long-term consequences of transplant AKI, novel interventions in the management of delayed graft function (DGF), and noninvasive diagnostic strategies.
The incidence and outcomes of nontransplant AKI are well documented, and similar data are emerging in the transplant setting with recent reports suggesting a high incidence rate and significant impact on long-term graft outcomes. DGF represents a 'pure' form of transplant AKI, and many interventional trials aiming to limit ischemia-reperfusion-induced injury have recently been reported or are currently ongoing. The search for accurate noninvasive predictors of DGF and acute rejection is ongoing and recent literature describes novel plasma and urine-based biomarkers as well as transcriptional profiling methods with high potential for clinical applicability.
AKI in transplant recipients is a frequent occurrence with significant potential for poor long-term graft outcomes. Recent efforts to limit ischemia-reperfusion injury and diagnose transplant AKI via noninvasive methods may help to minimize the impact of AKI on future graft function.
移植受者急性肾损伤(AKI)是一种普遍存在的疾病,其潜在的致病因素很多。本综述重点介绍了描述移植 AKI 的流行病学和长期后果、延迟移植物功能(DGF)管理中的新干预措施以及非侵入性诊断策略的最新数据。
非移植性 AKI 的发病率和结局已有充分记录,在移植环境中也出现了类似的数据,最近的报告表明发病率高,对长期移植物结局有重大影响。DGF 代表一种“纯粹”的移植 AKI,最近有许多旨在限制缺血再灌注损伤的干预试验已经报告或正在进行。寻找 DGF 和急性排斥反应的准确非侵入性预测因子的研究正在进行中,最近的文献描述了新型基于血浆和尿液的生物标志物以及转录谱分析方法,具有很高的临床应用潜力。
移植受者 AKI 是一种常见疾病,其对长期移植物功能有很大的潜在不良影响。最近通过非侵入性方法限制缺血再灌注损伤和诊断移植 AKI 的努力可能有助于减少 AKI 对未来移植物功能的影响。